（２）募集人数 特に定めないTanabe Mitsubishi Pharmaceutical Co., Ltd. (Headquarters: Chuo-ku, Osaka; President and Representative Director: Akihiro Tsujimura; hereinafter referred to as "Tanabe Mitsubishi Pharmaceutical") has decided to implement the following Voluntary Retirement Program (hereinafter referred to as the "Program") as follows.
1. Reasons for Recruiting Voluntary Retirees
The business environment surrounding the pharmaceutical industry is becoming more severe due to the advancement and complexity of research and development of new drugs, promotion of measures to suppress medical and drug costs, and other factors. In order to overcome such environmental changes, Tanabe Mitsubishi Pharmaceutical has been committed to focusing on research and development, mainly for rare diseases, as a pharmaceutical company with its own drug discovery type, and to promoting business expansion in North America, a growth market, and building a stable management foundation and optimal allocation of management resources. However, in order to continuously increase corporate value, it is necessary to further strengthen business in growth markets, mainly in North America, while maintaining a domestic business infrastructure, and it is essential to promote both growth strategies and structural reforms in tandem. We aim to be a growing company in the global market and have decided to implement this Program in order to accelerate the review of our human resources portfolio for realizing "an organization where personnel who have the capabilities necessary for implementing growth strategies," "highly specialized personnel," and "diverse personnel" can work actively.
2. Overview
(1) Eligible Employees: Employees aged 45 or older as of January 1, 2025, with a length of service of 5 years or more.
(2) Number of Recruits: Not specified.
(3) Recruitment Period: From October 1, 2024 to October 11, 2024 (planned).
(4) Retirement Date: December 31, 2024.
(5) Preferential measures: Payment of an increased retirement allowance in addition to the normal retirement allowance
Reemployment support services will be provided to those who wish to use them.
Contact
Pharma Strategy Division, PR Department, Tanabe Mitsubishi Pharmaceutical Co., Ltd.
TEL: 06-6205-5119
News for 2024